The role and mechanism of action of microbiota-derived short-chain fatty acids in neutrophils: From the activation to becoming potential biomarkers

• Published in: Biomedicine & pharmacotherapy Vol. 169; p. 115821
• Main Authors: Yan, Qingzhu, Jia, Shengnan, Li, Dongfu, Yang, Junling
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 31.12.2023; Elsevier
• Subjects: Apoptosis; Biomarker; Cancer; Infectious diseases; Inflammatory bowel disease; Neutrophil; Phagocytosis; Short-chain fatty acids; Inflammatory bowel disease; Short-chain fatty acids; Biomarker; Infectious diseases; Neutrophil; Phagocytosis; Apoptosis; Cancer
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115821

Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, have emerged as critical mediators in the communication between the human microbiota and its host. As the first responder to the inflammatory site, neutrophils play an important role in protecting the host against bacterial infections. Recent investigations revealed that SCFAs generated from microbiota influence various neutrophil activities, including activation, migration, and generation of mediators of inflammatory processes. SCFAs have also been demonstrated to exhibit potential therapeutic benefits in a variety of disorders related to neutrophil dysfunction, including inflammatory bowel disease, viral infectious disorders, and cancer. This study aims to examine the molecular processes behind the complicated link between SCFAs and neutrophils, as well as their influence on neutrophil-driven inflammatory disorders. In addition, we will also provide an in-depth review of current research on the diagnostic and therapeutic value of SCFAs as possible biomarkers for neutrophil-related diseases.